Morningstar Inc. MORN is set to report third-quarter 2015 results on Oct 21. Last quarter, it posted a 2.86% positive surprise. Let's see how things are shaping up for this announcement.
Factors at Play
Morningstar's second quarter earnings of 72 cents exceeded the Zacks Consensus Estimate of 70 cents. Moreover, it increased 7.5% from both the prior and the year-ago quarters. The company's consolidated revenues of $202.1 million were up 6.5% sequentially and 6.7% from the year-ago quarter.
The results were driven by strong performance of Morningstar Direct, Morningstar Data, Morningstar Retirement Solutions and Morningstar Credit Ratings, the structured credit research and ratings businesses of the company.
Currency movements majorly affected results during the quarter. It adversely impacted operating income by $1.1 million, including a negative effect on revenues of $7.6 million and a favorable effect on operating expense of $6.5 million.
But the company's focus on investing in its key growth initiatives will drive results in the to-be reported quarter.
Stocks to Consider
You can consider the following stocks with a favorable combination of a positive Earnings ESP and Zacks Rank #1, 2 or 3:
Amgen Inc. AMGN , with an Earnings ESP of +1.27% and a Zacks Rank #1.
Anika Therapeutics Inc. ANIK , with an Earnings ESP of +2.94% and a Zacks Rank #1.
SkyWest Inc. SKYW , with an Earnings ESP of +4.55% and a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AMGEN INC (AMGN): Free Stock Analysis Report
SKYWEST INC (SKYW): Free Stock Analysis Report
ANIKA THERAPEUT (ANIK): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.